lentiviral vectors

Revolutionary System Boosts Lentiviral Vector Production

📝 Scaling-up production of lentiviral vectors (LV)-based therapies is a challenge for biomanufacturers. 😎🔬 McGill University researchers have developed a semi-continuous manufacturing system that enhances the quantity and recovery of LVs, reduces instability, and cuts processing time by four-fold. ⏱️💪 The system integrates upstream and downstream bioprocesses, resulting in significant time savings. 💡✨ It operates by rotating membranes between two systems, improving efficiency. 🔄🔝